Rosuvastatin (calcium)
Key facts
| Invented name |
Crestor and associated names
|
| Active substance |
rosuvastatin calcium
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/229/2010
|
| PIP number |
Rosuvastatin (calcium)
|
| Pharmaceutical form(s) |
Film-coated tablet
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
AstraZeneca AB (UK)
Tel. +44 2073045345 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-000022-PIP01-07-M04
|
| Compliance opinion date |
11/10/2013
|
| Compliance outcome |
positive
|